AB
Insider buying
Ah Bio Fund Ii, L.P. bought $5M of Scribe Therapeutics, Inc. (SCTX) stock
Ah Bio Fund Ii, L.P., 10% owner of Scribe Therapeutics, Inc. (SCTX), bought 333,333 shares of SCTX stock worth $5M, per an SEC Form 4 filed Jul 29, 2026.
It was an open-market purchase.
The trade happened on Jul 27, 2026, 2 days before it was made public.
SCTX has moved +47.9% since the trade date, from $18.97 to $28.05 (Sep 21, 2026 close).
- Traded
- Jul 27, 2026
- Disclosed
- Jul 29, 2026
- Filing delay
- 2 days
- Price since
- +47.9%
- Role
- 10% owner
- Source
- SEC Form 4
More SCTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.